Mark Cuban Shares His Plan For Fixing Drug Prices in America | The Real Eisman Playbook Ep 50

Radical transparency with fixed 15% markup

Cost Plus Drugs publishes actual acquisition costs and applies a standard 15% markup, offering medications like the Stelara biosimilar Stargeza for $365 compared to $30,000 quarterly charges elsewhere.

Bypassing traditional pharmacy networks

The company eliminates Pharmacy Benefit Managers (PBMs) entirely, shipping generic, biosimilar, and select brand medications directly to consumers with no hidden fees or rebate schemes.

Doctors ignore cost conversations

Cuban notes physicians rarely discuss affordability, simply asking which pharmacy patients use rather than explaining that identical medications might cost $1,000 through insurance or $100 through Cost Plus.

Patients pay rebates during deductible phase

PBMs extract rebates from manufacturers (e.g., $400 on a $1,000 drug) for formulary placement, but patients paying deductibles are charged the full retail price while PBMs and employers pocket the rebate difference.

Multiple layers of hidden fees

Group purchasing organizations owned by PBMs take a 10-20% 'vig' from rebates before passing remainder to employers, who use these funds to lower premiums rather than reduce patient drug costs.

Sickest patients subsidize the healthy

Because rebates only generate when prescriptions are filled, patients with chronic illnesses meeting deductibles effectively pay inflated prices that subsidize premium reductions for healthier employees.

Hospitals as subprime lenders

When patients cannot afford $1,500-$5,000 deductibles, hospitals must loan them money to access insurance payments, knowing many patients will default but needing to unlock insurer funds.

Insurance payment games drive facility fees

Insurers underpay, late-pay, and audit hospitals, forcing providers to invent facility fees and location-based pricing surcharges to cover losses from delayed or denied reimbursements.

Fatal consequences of cost rationing

Cuban cites a truck driver who skipped heart medication due to unaffordable deductible costs, causing him to pass out while driving and kill four people—a tragedy caused by the rebate-driven pricing structure.